Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)
Ceiling: $400,000
Applications Due:
Closed
Federal
U.S. Department of Health and Human Services (National Institutes of Health)
Description
The purpose of this notice of funding opportunity (NOFO) is to support research that 1) defines associations between variations in human leukocyte antigen (HLA) and killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, 2) elucidates mechanisms underlying these associations with the goal of advancing therapeutic opportunities, and/or 3) validates association data in order to improve the predictive power of clinical disease screening.
Eligibility
States
All
Regions
All
Eligible Entities
State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal organizations, Public housing authorities, Nonprofits
Funding
Program Funding
Award Ceiling
$400,000
Award Floor
Award Count
Timing
Posted Date
April 24, 2024
App Status
No Longer Accepting Applications
Funder
Funding Source
Source Type
Federal
Contact Name
Contact Email
Contact Phone
--